The Valley Desk

Clinical trial reportThe oncologistPublished

A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The oncologist
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Benzimidazoles; Hydroxychloroquine; Mitogen-Activated Protein Kinase Kinases; Antineoplastic Combined Chemotherapy Protocols; Mutation; Middle Aged; Female; Male; Proto-Oncogene Proteins p21(ras)
PubMed ID
37186063
PubMed Central ID
PMC10322125
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal